Toth Financial Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-300
Closed -$22K 750
2021
Q3
$22K Hold
300
﹤0.01% 384
2021
Q2
$28K Hold
300
﹤0.01% 335
2021
Q1
$27K Buy
300
+200
+200% +$19.8K ﹤0.01% 346
2020
Q4
$9K Buy
+100
New +$7.97K ﹤0.01% 414

Other funds holding ARKG

Toth Financial Advisory's ARKG Position: Q4 2021 in Review

Toth Financial Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 300 shares — an estimated $22K sold.

Toth Financial Advisory first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $28K in Q2 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Toth Financial Advisory reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Toth Financial Advisory sold 300 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $22K.
  • Toth Financial Advisory first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
  • Toth Financial Advisory's ARK Genomic Revolution ETF position peaked at $28K in Q2 2021.
  • 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Toth Financial Advisory's 13F filing for Q4 2021, filed 31 Jan 2022.